ShadowBuys
Sign inJoin for free

Agios Pharmaceuticals (AGIO)

Healthcare · Biotechnology

2 members of Congress have disclosed 6 trades in Agios Pharmaceuticals (AGIO) since 2024: 6 buys and 0 sales. The most recent was disclosed on Sep 10, 2026.

Trades disclosed
6
Members trading
2
Buys / sells
6 / 0
Reported value
$6K–$90K

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow AGIO

What else is happening at AGIO

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. AGIOFinancial report·SEC EDGAR

    AGIO: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 5, 2026, 9:38 AM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. AGIOCompany announcement·SEC EDGAR

    AGIO: Financial results

    Filed 8-K for an event or period dated 2026-11-05. Financial results.

    Public: Nov 5, 2026, 6:33 AM ESTEvent / period: Nov 5, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Who traded AGIO

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.